Mike Doustdar Talks Strong Demand for Weight Loss Pills
Bloomberg Talks
00:00
Competition and formulation advantages
Katie asks about Lilly's pill; Mike highlights Novo Nordisk's oral peptide achievement and matching pen efficacy.
Play episode from 02:09
Transcript
